← Leaderboards
Dwi Utami Kemaladewi
University Of Pittsburgh At Pittsburgh
$3,083,120
Attributed
$3,083,120
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.3M · FY2021–24$2M$1.5M$1M$500K$0
'21
'22
'23
'24
Funding mix
By agency
NIH$3,083,120 · 2
By mechanism
DP2$2,200,578 · 1
R01$882,542 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Xiao Xiao$14,631,158
- Paul R. Kinchington$19,833,198
- Anthony John Kanai$13,693,260
- Stephen A Murray$43,730,323
- James R Goss$1,944,536
Others in their field
Other Emerging Leaders on “Patient Population”
- Beth Baseler · Leidos Biomedical Research, Inc.$87,027,148
- Susan Abushakra · Alzheon, Inc.$47,265,244
- Scott Topper · Broad Institute, Inc.$40,892,828
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$39,627,795
- Abraham Aizer Brody · New York University School Of Medicine$37,005,042
- James Dale Berry · Brigham And Women'S Hospital$34,837,233
Research focus
Patient PopulationClinical TrialsMutationSafetyExperimental StudyDisease PhenotypeFutureMuscular DystrophiesTechnologyTherapeutic InterventionGeneticCellsAnimalsCessation Of LifeCell MotilityCell ModelAwardAdverse OutcomeCostCareerContractureCrispr/Cas TechnologyCrispr-Mediated Transcriptional ActivationCongenital Muscular Dystrophy
Grant awards (4)
Implications of Genetic Diversity in Muscular Dystrophy$931,491
DP2 · FY2024 · AR · contact PI
Therapeutic genetics and disease modeling in LAMA2-CMD$441,089
R01 · FY2023 · AR · contact PI
Therapeutic genetics and disease modeling in LAMA2-CMD$441,453
R01 · FY2022 · AR · contact PI
Implications of Genetic Diversity in Muscular Dystrophy$1,269,087
DP2 · FY2021 · AR · contact PI